국립중앙도서관 "우편 복사 서비스"로 연결 됩니다.
KCIEpithelial growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used for non-small-cell lung cancer patients. Its untoward cutaneous effects are largely well known and developed in many patients treated with EGFR TKIs. Howe...
다국어 입력
あ
ぁ
か
が
さ
ざ
た
だ
な
は
ば
ぱ
ま
や
ゃ
ら
わ
ゎ
ん
い
ぃ
き
ぎ
し
じ
ち
ぢ
に
ひ
び
ぴ
み
り
う
ぅ
く
ぐ
す
ず
つ
づ
っ
ぬ
ふ
ぶ
ぷ
む
ゆ
ゅ
る
え
ぇ
け
げ
せ
ぜ
て
で
ね
へ
べ
ぺ
め
れ
お
ぉ
こ
ご
そ
ぞ
と
ど
の
ほ
ぼ
ぽ
も
よ
ょ
ろ
を
ア
ァ
カ
サ
ザ
タ
ダ
ナ
ハ
バ
パ
マ
ヤ
ャ
ラ
ワ
ヮ
ン
イ
ィ
キ
ギ
シ
ジ
チ
ヂ
ニ
ヒ
ビ
ピ
ミ
リ
ウ
ゥ
ク
グ
ス
ズ
ツ
ヅ
ッ
ヌ
フ
ブ
プ
ム
ユ
ュ
ル
エ
ェ
ケ
ゲ
セ
ゼ
テ
デ
ヘ
ベ
ペ
メ
レ
オ
ォ
コ
ゴ
ソ
ゾ
ト
ド
ノ
ホ
ボ
ポ
モ
ヨ
ョ
ロ
ヲ
―
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
예시)
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
А
Б
В
Г
Д
Е
Ё
Ж
З
И
Й
К
Л
М
Н
О
П
Р
С
Т
У
Ф
Х
Ц
Ч
Ш
Щ
Ъ
Ы
Ь
Э
Ю
Я
а
б
в
г
д
е
ё
ж
з
и
й
к
л
м
н
о
п
р
с
т
у
ф
х
ц
ч
ш
щ
ъ
ы
ь
э
ю
я
′
″
℃
Å
￠
￡
￥
¤
℉
‰
＄
％
Ｆ
￦
㎕
㎖
㎗
ℓ
㎘
㏄
㎣
㎤
㎥
㎦
㎙
㎚
㎛
㎜
㎝
㎞
㎟
㎠
㎡
㎢
㏊
㎍
㎎
㎏
㏏
㎈
㎉
㏈
㎧
㎨
㎰
㎱
㎲
㎳
㎴
㎵
㎶
㎷
㎸
㎹
㎀
㎁
㎂
㎃
㎄
㎺
㎻
㎽
㎾
㎿
㎐
㎑
㎒
㎓
㎔
Ω
㏀
㏁
㎊
㎋
㎌
㏖
㏅
㎭
㎮
㎯
㏛
㎩
㎪
㎫
㎬
㏝
㏐
㏓
㏃
㏉
㏜
㏆
RISS 인기검색어
https://www.riss.kr/link?id=A104548049
- 저자
- 발행기관
- 학술지명
- 권호사항
-
발행연도
2013
-
작성언어
English
- 주제어
-
등재정보
KCI등재,SCOPUS,ESCI
-
자료형태
학술저널
-
수록면
37-40(4쪽)
-
KCI 피인용횟수
0
- 제공처
-
0
상세조회 -
0
다운로드
부가정보
다국어 초록 (Multilingual Abstract)
Epithelial growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used for non-small-cell lung cancer patients. Its untoward cutaneous effects are largely well known and developed in many patients treated with EGFR TKIs. However trichomegaly of eyelash is rarely reported. Although trichomegaly is not a drug-limiting side effect, it could be troublesome of continuing the treatment because of cosmetic issue or eyeball irritation by long eyelashes. Therefore clinicians are needed to pay attention to this uncommon effect. We herein describe erlotinib induced trichomegaly of eyelashes in a woman with adenocarcinoma of the lung.
참고문헌 (Reference)
1 Bouche O, "Trichomegaly of the eyelashes following treatment with cetuximab" 16 : 1711-1712, 2005
2 Carser JE, "Trichomegaly of the eyelashes after treatment with erlotinib in non-small cell lung cancer" 1 : 1040-1041, 2006
3 Braiteh F, "Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib" 26 : 3460-3462, 2008
4 Pascual JC, "Trichomegaly following treatment with gefitinib (ZD1839)" 151 : 1111-1112, 2004
5 Shah NT, "Practical management of patients with non-small-cell lung cancer treated with gefitinib" 23 : 165-174, 2005
6 Albanell J, "Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition" 20 : 110-124, 2002
7 Eisenhauer EA, "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)" 45 : 228-247, 2009
8 Lane K, "Erlotinib-associated trichomegaly" 23 : 65-66, 2007
9 Daniele L, "Epidermal growth factor receptor gene in primary tumor and metastatic sites from nonsmall cell lung cancer" 4 : 684-688, 2009
10 Perez-Soler R, "Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer" 22 : 3238-3247, 2004
1 Bouche O, "Trichomegaly of the eyelashes following treatment with cetuximab" 16 : 1711-1712, 2005
2 Carser JE, "Trichomegaly of the eyelashes after treatment with erlotinib in non-small cell lung cancer" 1 : 1040-1041, 2006
3 Braiteh F, "Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib" 26 : 3460-3462, 2008
4 Pascual JC, "Trichomegaly following treatment with gefitinib (ZD1839)" 151 : 1111-1112, 2004
5 Shah NT, "Practical management of patients with non-small-cell lung cancer treated with gefitinib" 23 : 165-174, 2005
6 Albanell J, "Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition" 20 : 110-124, 2002
7 Eisenhauer EA, "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)" 45 : 228-247, 2009
8 Lane K, "Erlotinib-associated trichomegaly" 23 : 65-66, 2007
9 Daniele L, "Epidermal growth factor receptor gene in primary tumor and metastatic sites from nonsmall cell lung cancer" 4 : 684-688, 2009
10 Perez-Soler R, "Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer" 22 : 3238-3247, 2004
11 Busam KJ, "Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225" 144 : 1169-1176, 2001
동일학술지(권/호) 다른 논문
-
Recent Advances in Idiopathic Pulmonary Fibrosis
- 대한결핵 및 호흡기학회
- Sang Hoon Park
- 2013
- KCI등재,SCOPUS,ESCI
-
Measurement of Fractional Exhaled Nitric Oxide in Stable Bronchiectasis
- 대한결핵 및 호흡기학회
- ( Young Jae Cho )
- 2013
- KCI등재,SCOPUS,ESCI
-
Predictors of Cardiogenic and Non-Cardiogenic Causes in Cases with Bilateral Chest Infiltrates
- 대한결핵 및 호흡기학회
- ( Yeon Joo Lee )
- 2013
- KCI등재,SCOPUS,ESCI
-
A Case of Multicentric Castleman's Disease Presenting with Follicular Bronchiolitis
- 대한결핵 및 호흡기학회
- Yup Hwang Bo
- 2013
- KCI등재,SCOPUS,ESCI
분석정보
인용정보 인용지수 설명보기
학술지 이력
| 연월일 | 이력구분 | 이력상세 | 등재구분 |
|---|---|---|---|
| 2023 | 평가예정 | 해외DB학술지평가 신청대상 (해외등재 학술지 평가) | |
| 2020-01-01 | 평가 | 등재학술지 유지 (해외등재 학술지 평가) |  |
| 2011-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
| 2009-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
| 2007-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
| 2004-07-30 | 학술지명변경 | 한글명 : 결핵 및 호흡기질환 -> Tuberculosis and Respiratory Diseases | |
| 2004-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | |
| 2003-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) |  |
| 2002-01-01 | 평가 | 등재후보학술지 유지 (등재후보1차) | |
| 2000-01-01 | 평가 | 등재후보학술지 선정 (신규평가) | |
학술지 인용정보
| 기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
|---|---|---|---|
| 2016 | 0.21 | 0.21 | 0.2 |
| KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
| 0.19 | 0.15 | 0.475 | 0.2 |
이 자료와 함께 이용한 RISS 자료
나만을 위한 추천자료
